ABINGDON HEALTH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10 GBX | -4.76% |
|
0.00% | -9.09% |
| May. 07 | Abingdon Health buys IVDeology Holdings | AN |
| May. 07 | Abingdon Health Plc acquired Ivdeology Holdings Ltd for £0.7 million. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.84M 3.54M | Sales 2023 | 4.04M 5.05M | Capitalization | 36.95M 46.18M |
|---|---|---|---|---|---|
| Net income 2022 | -21M -26.24M | Net income 2023 | -3M -3.75M | EV / Sales 2022 | 11.6 x |
| Net cash position 2022 | 1.12M 1.4M | Net cash position 2023 | 2.22M 2.77M | EV / Sales 2023 | 8.59 x |
| P/E ratio 2022 |
-1.57
x | P/E ratio 2023 |
-10.5
x | Employees | 84 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.64% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | -4.76% | ||
| 1 month | -9.09% | ||
| 3 months | +11.11% | ||
| 6 months | -1.48% | ||
| Current year | -9.09% |
1 week
9.50
10.70
1 month
9.5011.20
Current year
6.5013.00
1 year
6.5018.50
3 years
3.6085.00
5 years
3.60136.65
10 years
3.60136.65
| Managers | Title | Age | Since |
|---|---|---|---|
Chris Yates
FOU | Founder | 50 | 08-01-15 |
| Founder | 63 | 08-01-15 | |
Andrew Feather
DFI | Director of Finance/CFO | - | 23-10-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 63 | 08-01-15 | |
Mary Tavener
BRD | Director/Board Member | 62 | 20-10-25 |
Chris Yates
FOU | Founder | 50 | 08-01-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 10 | -4.76% | 82,338 |
| 24-05-07 | 10.5 | +7.69% | 273,046 |
| 24-05-03 | 9.75 | 0.00% | 102,989 |
| 24-05-02 | 9.75 | -2.50% | 166,322 |
| 24-05-01 | 10 | 0.00% | 63,185 |
Delayed Quote London S.E., May 08, 2024 at 11:35 am EDT
More quotes
Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Companyâs CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an ecommerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.
Calendar
2024-11-13
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.09% | 40.56M | |
| -1.49% | 12.71B | |
| +0.13% | 8.37B | |
| -1.12% | 5.4B | |
| +20.18% | 5.27B | |
| -0.74% | 4.63B | |
| -54.68% | 3.13B | |
| +24.56% | 2.77B | |
| -8.47% | 2.25B | |
| -1.86% | 1.95B |
- Stock Market
- Equities
- ABDX Stock